drugset / Trial / NCT06326112
Role of Active Deresuscitation After Resuscitation:
Phase 2
Unknown
120 enrolled
Unity Health Toronto
Canadian Institutes of Health Research (CIHR) · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The RADAR-Canada trial is a pilot RCT undertaken to assess the acceptability of, compliance with, and biologic consequences of a deresuscitation protocol designed to expedite the removal of excess interstitial fluid in patients who remain in a positive fluid balance following admission to an intensive care unit (ICU).
Timeline
- Start
- 2024-05-01
- Primary completion
- 2025-03-31
- Completion
- 2025-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Furosemide | Other / unclassified | 0.5 mg/kg | Intravenous |
| Subject | Metolazone | Small molecule | — | — |